Liquichek Elevated CRP Control Levels 1, 2 and 3: Revision Date 2022-05-26 Indicates Revised Information
Liquichek Elevated CRP Control Levels 1, 2 and 3: Revision Date 2022-05-26 Indicates Revised Information
Liquichek Elevated CRP Control Levels 1, 2 and 3: Revision Date 2022-05-26 Indicates Revised Information
https://www.myeinserts.com/90900
METHOD (1)
Level 1 - 90901 Level 2 - 90902 (2) Level 3 - 90903 (2)
Units Mean Range Mean Range Mean Range
C-REACTIVE PROTEIN (CRP)
Abbott ARCHITECT cSystems mg/dL 1.31 0.979 – 1.64 8.48 7.18 – 9.78 19.7 16.8 – 22.5
Abbott ARCHITECT cSystems (Sentinel Vario) mg/dL 1.21 0.895 – 1.52 8.22 6.96 – 9.48 18.3 15.7 – 20.9
Beckman Coulter AU Systems (OSR6147) mg/dL § § §
Beckman Coulter AU Systems (OSR6199) mg/dL 1.25 1.02 – 1.48 8.69 7.63 – 9.75 17.2 15.2 – 19.2
Beckman Coulter IMMAGE mg/dL 1.25 0.926 – 1.58 8.58 7.29 – 9.88 18.3 15.7 – 20.9
Beckman Coulter Synchron / UniCel DxC Series mg/dL 0.938 0.657 – 1.22 8.39 7.10 – 9.68 18.8 16.1 – 21.5
Nihon Kohden Celltac Chemi CRP4 (3) mg/dL 1.22 0.980 – 1.46 7.72 6.18 – 9.26 17.1 13.7 – >20.0
Nihon Kohden Celltac Chemi CRP4N (3) mg/dL 1.19 1.02 – 1.36 8.08 6.87 – 9.29 18.5 15.7 – >20.0
Ortho Vitros Microslide Series mg/dL 1.58 0.628 – 2.53 11.1 8.22 – 14.0 23.4 18.0 – 28.8
Radiometer AQT90 FLEX (3) mg/dL 1.31 1.04 – 1.57 8.34 6.67 – 10.1 18.0 14.3 – 21.6
Roche / Hitachi Cobas c Systems (CRPL3) mg/dL 1.13 1.02 – 1.24 8.41 6.88 – 9.94 18.5 15.1 – 21.9
Roche cobas INTEGRA (CRP4) mg/L 11.3 9.06 – 13.6 80.6 69.5 – 91.7 160 139 – 181
Roche cobas INTEGRA (CRPLX) mg/dL § § §
Siemens ADVIA Chemistry Systems (CRP_2) mg/dL § § §
Siemens ADVIA Chemistry Systems (wrCRP) mg/dL 1.34 1.15 – 1.54 8.40 7.59 – 9.20 17.2 15.6 – 18.7
Siemens BN II / BN ProSpec mg/dL 1.09 0.890 – 1.29 8.03 6.83 – 9.22 17.6 15.2 – 20.0
Siemens Dimension Series (RCRP) mg/dL 1.23 0.349 – 2.10 8.25 6.53 – 9.97 18.5 15.5 – 21.5
Siemens Dimension Vista Systems mg/dL 1.20 0.981 – 1.42 7.80 6.60 – 8.99 15.6 13.3 – 18.0
FOOTNOTES
(1) All footnotes may not apply to your custom selected data chart.
(2) This product should be run with automatic dilution, the same as patient samples.
(3) The assigned values were determined using the reagent and/or instrument manufacturer’s protocol and may not represent ±3SD ranges.
§ The data required to establish the means and acceptable ranges for this assay were not obtained due to limited assignment participation. If your facility is
interested in participating in the Value Assignment Program for this assay, please contact your local Bio-Rad office.